Conclusions and Next Steps. This document provides a thorough review of the state of the art in trust modelling, covering both human and machine aspects as well as trustworthiness by design approaches. We have described the trust aspects of 4G networks through defining the actors and business models and their consequences for trust. We note that there is no formal specification of trust in 4G networks to report on or build upon. Looking to the future we have documented the new actors and business models expected in 5G networks including the consequences of virtualisation, new domains and tighter integration of satellite and HAPS systems. This is followed by an analysis of the majority of the 5G use cases defined in 5G-ENSURE D2.1 where in each case the entities and trust issues are enumerated. Taking all this into account we have discussed the role of privacy in 5G and propose an approach to modelling trust in 5G networks, extending the state of the art. This “draft” trust model document contains a large amount of documentation and analysis. The 5G use case analysis will be completed and the entirety will then be combined with further information from various sources to analyse the architecture and potential risks in more detail: the CAPEC database [Mitre-3] of known attacks to ensure that a broad range of known malicious attacks is modelled; deliverable D2.4 “Security architecture (draft)” and 5G architecture documents from elsewhere for details on generic 5G stakeholder roles and technology asset types once they are determined. The results of the analysis will then be captured in a machine understandable form, and algorithms defined for quantification of trust (and trustworthiness) going beyond the simple ones proposed in this report. All of these results will then feed into the development of security architecture in WP2, also trust enablers in WP3, as well as the specification of the full 5G-ENSURE trust model in Deliverable D2.5 which will include an analysis of the 5G-ENSURE trust enablers.
Conclusions and Next Steps. 33 PROJECT SUMMARY
Conclusions and Next Steps. This document sets the framework for best disseminating and exploiting the ESCAPE results to the defined targeted audience. Ensuring a consistent dissemination and exploitation plan to the stakeholders as well as among users is of foremost importance. Collaboration among project partners for sharing of result and building on dynamicity and adaptability are key words for successful project dissemination and exploitation.
Conclusions and Next Steps. Xxxxxxxx from the analysis of the innovation background and the supply-chain descriptions in this document, in the next period the Stakeholder Analysis will start and a through validation phase will be completed with the industrial partners within the consortium, to use this market framework for assessing the potential of the project and produce a complete technology and business study, via a knowledge-based intelligence.
Conclusions and Next Steps. The established processes and lexicons are acceptable for use of evaluating soymilk and tofu. Moving forward, the GFTC will be incorporating the above suggestions from the Japanese collaborators into their soymilk and tofu production to refine their techniques. Xxxxxxx X.X. and Xxxx X.X. 1996. Aroma and Flavor Lexicon for Sensory Evaluation. ASTM Data Series Publication DS 66.
Conclusions and Next Steps presents a new approach to CW-SEIT based on an extensive review of V1.0, an updated analysis of the cyber risk landscape and direct interaction with SMEs, which have little understanding of the risks they are facing, let alone the resources to implement a risk management strategy.
Conclusions and Next Steps. The IVOA interoperability meeting was a successful second milestone for CEVO. The ESCAPE project was very visible at this international interoperability meeting, and progress was made in a number of priority areas for the ESFRI and other research infrastructures, in particular in relation to radio astronomy. The next IVOA interoperability meeting will be held in Sydney, Australia May 4-8, 2020. A CEVO Technology Forum event (Feb 4-6, 2020) will prepare for the ESCAPE input to this next meeting. We expect that the ESCAPE Progress Meeting (February 2020), and other CEVO specific meetings will also provide important input for the preparation of the next IVOA meeting milestone.
Conclusions and Next Steps. More complete documentation and the hiring of specific staff with area expertise will augment the service and subsequent higher fidelity ratings. Several important areas of focus will be followed by BMHS going forward. We recommend that NHS develop and submit an action plan that addresses the specific goals and measurable objectives that can be implemented toward better fidelity overall, prioritizing the fidelity items where ratings have declined or are 3 or below (see table 1.). We look forward to your response within two weeks of receipt of this final report. NHS ACT Fidelity Review Comparisons BERLIN XXXXXX XXXXXXXXX NHS AGGREGATE 2015 2016 2015 0000 0000 0000 2015 2016 H1 - Small Caseload 5 4 5 5 5 5 5.0 4.7 H2 - Team Approach 5 3 2 4 2 3 3.0 3.3 H3 - Program Meeting 5 4 5 4 3 3 4.3 3.7 H4 - Practicing ACT Leader 1 5 2 4 2 5 1.7 4.7 H5 - Staff Continuity 5 3 3 5 4 5 4.0 4.3 H6 - Staff Capacity 5 4 5 5 4 5 4.7 4.7 H7 - Psychiatry 4 4 5 5 5 2 4.7 3.7 H8 - Nursing 2 2 2 3 3 2 2.3 2.3 H9 - Substance Abuse 2 2 5 2 1 4 2.7 2.7 H10 - Vocational (SE) 2 2 4 3 3 4 3.0 3.0 O1 - Admission Criteria 5 5 4 5 5 5 4.7 5.0 O2 - Intake Rate 5 5 5 5 5 5 5.0 5.0 O3 - Service Responsibility 4 5 4 5 4 5 4.0 5.0 O4 - Crisis Responsibility 5 1 3 4 3 1 3.7 2.0 O5 - Hospital Admits 5 5 4 5 4 5 4.3 5.0 O6 - Hospital Discharges 4 5 3 5 4 5 3.7 5.0 S1 - Community-Based Svcs 5 4 4 5 5 5 4.7 4.7 S2 - No Dropout Policy 5 5 4 5 5 5 4.7 5.0 S3 - Assertive Engagement 5 5 3 5 4 5 4.0 5.0 S4 - Intensity of Svcs 4 3 4 3 4 2 4.0 2.7 S6 - Work with Support Sys 4 4 4 4 4 4 4.0 4.0 S10 - Consumer on Team 2 1 3 3 3 3 2.7 2.3 TOTAL MEAN 105 3.8 99 3.5 101 3.6 114 4.1 95 3.4 104 3.7 100.3 3.6 105.7 3.8 TABLE 0 0000-0000 NHS ACT Fidelity Review score comparison. ACT Domain Item #/Score ACT Fidelity Feedback Score Corrective Action Steps
Conclusions and Next Steps. This deliverable has sought to outline the main benefits that ten key customers and stakeholders in the value chain of V2B/V2G services would obtain from contracting them, or from participating in their provision. To do so, it has indicated present needs of each of the ten key stakeholders, as well as the contemporary difficulties and obstacles they face, and it has described how V2B/V2G could contribute to solving or mitigating some or all of them.
Conclusions and Next Steps. Six biomarkers soymilk and three biomarkers for tofu have been discovered. Compounds found in both the raw soybean seed and the end products can now be used to screen Sevita International’s germplasm to determine if there are any particular varieties that can be identified for end user testing and future sensory evaluation studies.
